3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
33
Lung Neoplasms
13
Breast Neoplasms
12
Colorectal Neoplasms
11
Ovarian Neoplasms
10
Recurrence
9
Neoplasms
9
Small Cell Lung Carcinoma
8
Neoplasm Metastasis
8
Head and Neck Neoplasms
8
Urinary Bladder Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
7
Lymphoma, Large B-Cell, Diffuse
7
Prostatic Neoplasms
6
Carcinoma, Hepatocellular
6
Triple Negative Breast Neoplasms
5
Pancreatic Neoplasms
5
Diabetes Mellitus, Insulin-Dependent, 12
5
Carcinoma
5
Multiple Myeloma
4
Lymphoma, Follicular
4
Cholangiocarcinoma
4
Uterine Cervical Neoplasms
3
Recurrent Squamous Cell Lung Carcinoma
3
Oropharyngeal Neoplasms
3
Mouth Neoplasms
3
Mesothelioma
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Kidney Neoplasms
3
Interventions
Cyclophosphamide
13
Doxorubicin
9
Trastuzumab
8
Taxes
7
Paclitaxel
7
Docetaxel
5
Carboplatin
5
Albumin-Bound Paclitaxel
5
Radiotherapy
4
Epirubicin
4
pertuzumab
3
pembrolizumab
3
Melphalan
3
130-nm albumin-bound paclitaxel
3
eribulin
2
Thiotepa
2
Tamoxifen
2
Peripheral Blood Stem Cell Transplantation
2
Lapatinib
2
Fluorouracil
2
Filgrastim
2
Bevacizumab
2
2C4 antibody
2
trastuzumab biosimilar HLX02
1
talimogene laherparepvec
1
sargramostim
1
ruxolitinib
1
romidepsin
1
pegfilgrastim
1
pazopanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Inflammatory Breast Neoplasms
×
durvalumab
×
Clear all
No trials found.